| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1997PNAS...94.7388D |
| P356 | DOI | 10.1073/PNAS.94.14.7388 |
| P8608 | Fatcat ID | release_c7jcsjvhvndf3esbjsz2z4amfy |
| P932 | PMC publication ID | 23831 |
| P698 | PubMed publication ID | 9207101 |
| P5875 | ResearchGate publication ID | 14012486 |
| P2093 | author name string | D E Housman | |
| R H Singer | |||
| M E McCurrach | |||
| B M Davis | |||
| K L Taneja | |||
| P2860 | cites work | Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy | Q24328773 |
| Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction | Q25938986 | ||
| Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene | Q28285882 | ||
| Novel proteins with binding specificity for DNA CTG repeats and RNA CUG repeats: implications for myotonic dystrophy | Q28288794 | ||
| Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. | Q34290920 | ||
| An unstable triplet repeat in a gene related to myotonic muscular dystrophy | Q34355359 | ||
| Decreased expression of myotonin-protein kinase messenger RNA and protein in adult form of myotonic dystrophy. | Q34363062 | ||
| A novel homeodomain-encoding gene is associated with a large CpG island interrupted by the myotonic dystrophy unstable (CTG)n repeat | Q34374463 | ||
| Three-dimensional molecular distribution in single cells analysed using the digital imaging microscope | Q35994008 | ||
| Core filaments of the nuclear matrix | Q36222649 | ||
| Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues | Q36235446 | ||
| The regulation of export of mRNA from nucleus to cytoplasm | Q40725780 | ||
| Identification, Tissue-specific Expression, and Subcellular Localization of the 80- and 71-kDa Forms of Myotonic Dystrophy Kinase Protein | Q41302208 | ||
| Targeting of c-myc and beta-globin coding sequences to cytoskeletal-bound polysomes by c-myc 3' untranslated region | Q41487165 | ||
| Myotonic dystrophy: evidence for a possible dominant-negative RNA mutation | Q60050804 | ||
| Effect of Myotonic Dystrophy Trinucleotide Repeat Expansion on DMPK Transcription and Processing | Q62661555 | ||
| Highly localized tracks of specific transcripts within interphase nuclei visualized by in situ hybridization | Q69348638 | ||
| Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy | Q71167717 | ||
| Preferential nucleosome assembly at DNA triplet repeats from the myotonic dystrophy gene | Q72073093 | ||
| Effect of the myotonic dystrophy (DM) mutation on mRNA levels of the DM gene | Q72896182 | ||
| P433 | issue | 14 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | myotonic dystrophy | Q1860507 |
| P304 | page(s) | 7388-7393 | |
| P577 | publication date | 1997-07-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Expansion of a CUG trinucleotide repeat in the 3' untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts | |
| P478 | volume | 94 |
| Q40971215 | (CTG)n repeats markedly inhibit differentiation of the C2C12 myoblast cell line: implications for congenital myotonic dystrophy |
| Q47194897 | 250 CTG repeats in DMPK is a threshold for correlation of expansion size and age at onset of juvenile-adult DM1. |
| Q22254606 | A family of human RNA-binding proteins related to the Drosophila Bruno translational regulator |
| Q36378612 | A flow cytometry-based screen identifies MBNL1 modulators that rescue splicing defects in myotonic dystrophy type I. |
| Q36722690 | A low absolute number of expanded transcripts is involved in myotonic dystrophy type 1 manifestation in muscle. |
| Q38939914 | ABLIM1 splicing is abnormal in skeletal muscle of patients with DM1 and regulated by MBNL, CELF and PTBP1. |
| Q92827366 | AON-induced splice-switching and DMPK pre-mRNA degradation as potential therapeutic approaches for Myotonic Dystrophy type 1 |
| Q89936495 | Aberrant Expression of a Non-muscle RBFOX2 Isoform Triggers Cardiac Conduction Defects in Myotonic Dystrophy |
| Q74441599 | Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy |
| Q42437310 | Abnormal contractile activity and calcium cycling in cardiac myocytes isolated from DMPK knockout mice |
| Q38330480 | Activation of the innate immune response and interferon signalling in myotonic dystrophy type 1 and type 2 cataracts. |
| Q38547027 | Allele-selective suppression of mutant genes in polyglutamine diseases |
| Q24654728 | Altered phosphorylation and intracellular distribution of a (CUG)n triplet repeat RNA-binding protein in patients with myotonic dystrophy and in myotonin protein kinase knockout mice |
| Q24604643 | Altered ribostasis: RNA-protein granules in degenerative disorders |
| Q47929916 | Alternative splicing alterations of Ca2+ handling genes are associated with Ca2+ signal dysregulation in myotonic dystrophy type 1 (DM1) and type 2 (DM2) myotubes |
| Q36599506 | Alternative splicing and muscular dystrophy. |
| Q34219488 | Alternative splicing controls myotonic dystrophy protein kinase structure, enzymatic activity, and subcellular localization |
| Q34861423 | Alternative splicing dysregulation secondary to skeletal muscle regeneration |
| Q34716334 | Alternative splicing of human insulin receptor gene (INSR) in type I and type II skeletal muscle fibers of patients with myotonic dystrophy type 1 and type 2. |
| Q28244232 | Alternative splicing of myomesin 1 gene is aberrantly regulated in myotonic dystrophy type 1 |
| Q33857850 | An untranslated CTG expansion causes a novel form of spinocerebellar ataxia (SCA8) |
| Q42946576 | Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2). |
| Q56936089 | Analysis of extracellular mRNA in human urine reveals splice variant biomarkers of muscular dystrophies |
| Q36848720 | Antisense oligonucleotides: rising stars in eliminating RNA toxicity in myotonic dystrophy. |
| Q39012706 | Antisense transcription of the myotonic dystrophy locus yields low-abundant RNAs with and without (CAG)n repeat. |
| Q101559243 | Application of CRISPR-Cas9-Mediated Genome Editing for the Treatment of Myotonic Dystrophy Type 1 |
| Q36060807 | Artificial mirtron-mediated gene knockdown: functional DMPK silencing in mammalian cells |
| Q50310770 | Autism spectrum conditions in myotonic dystrophy type 1: a study on 57 individuals with congenital and childhood forms |
| Q41740863 | Base stacking and even/odd behavior of hairpin loops in DNA triplet repeat slippage and expansion with DNA polymerase |
| Q34470663 | Bidirectional transcription stimulates expansion and contraction of expanded (CTG)*(CAG) repeats. |
| Q55322911 | Bruno-3 regulates sarcomere component expression and contributes to muscle phenotypes of myotonic dystrophy type 1. |
| Q35942449 | Bsr, a nuclear-retained RNA with monoallelic expression |
| Q37877092 | CAG repeat RNA as an auxiliary toxic agent in polyglutamine disorders |
| Q30496276 | CUGBP1 overexpression in mouse skeletal muscle reproduces features of myotonic dystrophy type 1. |
| Q55100992 | Cells of Matter-In Vitro Models for Myotonic Dystrophy. |
| Q37897768 | Cellular toxicity of expanded RNA repeats: focus on RNA foci |
| Q52547985 | Characterization of cardiac conduction system abnormalities in mice with targeted disruption of Six5 gene. |
| Q40553411 | Chemically induced increases and decreases in the rate of expansion of a CAG*CTG triplet repeat |
| Q24650948 | Comparative genomics and molecular dynamics of DNA repeats in eukaryotes |
| Q43506355 | Comparative transcriptional and biochemical studies in muscle of myotonic dystrophies (DM1 and DM2). |
| Q36228044 | Cooperation meets competition in microRNA-mediated DMPK transcript regulation |
| Q92255896 | Correction of RNA-Binding Protein CUGBP1 and GSK3β Signaling as Therapeutic Approach for Congenital and Adult Myotonic Dystrophy Type 1 |
| Q43987903 | Correction of dystrophia myotonica type 1 pre-mRNA transcripts by artificial trans-splicing |
| Q38713995 | CpG Methylation, a Parent-of-Origin Effect for Maternal-Biased Transmission of Congenital Myotonic Dystrophy |
| Q40456301 | Cytoplasmic and nuclear retained DMPK mRNAs are targets for RNA interference in myotonic dystrophy cells. |
| Q41002587 | DDX6 regulates sequestered nuclear CUG-expanded DMPK-mRNA in dystrophia myotonica type 1. |
| Q33842956 | DMPK dosage alterations result in atrioventricular conduction abnormalities in a mouse myotonic dystrophy model |
| Q59071144 | DNA triplet repeats mediate heterochromatin-protein-1-sensitive variegated gene silencing |
| Q74609017 | Decreased levels of myotonic dystrophy protein kinase (DMPK) and delayed differentiation in human myotonic dystrophy myoblasts |
| Q24682706 | Defining early steps in mRNA transport: mutant mRNA in myotonic dystrophy type I is blocked at entry into SC-35 domains |
| Q41043651 | Definition of regulatory sequence elements in the promoter region and the first intron of the myotonic dystrophy protein kinase gene |
| Q37386187 | Derepressing muscleblind expression by miRNA sponges ameliorates myotonic dystrophy-like phenotypes in Drosophila. |
| Q30413238 | Development of an AP-FRET based analysis for characterizing RNA-protein interactions in myotonic dystrophy (DM1) |
| Q38287631 | Developmental insights into the pathology of and therapeutic strategies for DM1: Back to the basics |
| Q60950065 | Dissecting Pathogenetic Mechanisms and Therapeutic Strategies in Models of Myotonic Dystrophy Type 1 |
| Q64066391 | Distinct pathological signatures in human cellular models of myotonic dystrophy subtypes |
| Q41643458 | Dmpk gene deletion or antisense knockdown does not compromise cardiac or skeletal muscle function in mice |
| Q34252137 | Does (CUG)n repeat in DMPK mRNA 'paint' chromosome 19 to suppress distant genes to create the diverse phenotype of myotonic dystrophy?: A new hypothesis of long-range cis autosomal inactivation |
| Q34699401 | Dominantly inherited, non-coding microsatellite expansion disorders |
| Q92096984 | Dosage effect of multiple genes accounts for multisystem disorder of myotonic dystrophy type 1 |
| Q37713198 | Drosophila melanogaster As a Model Organism to Study RNA Toxicity of Repeat Expansion-Associated Neurodegenerative and Neuromuscular Diseases |
| Q34326165 | Dystrophia myotonia: why focus on foci? |
| Q73168300 | ETR-1, a homologue of a protein linked to myotonic dystrophy, is essential for muscle development in Caenorhabditis elegans |
| Q90058443 | Endurance exercise leads to beneficial molecular and physiological effects in a mouse model of myotonic dystrophy type 1 |
| Q37695480 | Epigenetic changes and non-coding expanded repeats |
| Q30408570 | Evaluating the effects of CELF1 deficiency in a mouse model of RNA toxicity |
| Q33649463 | Evidence for RNA-mediated toxicity in the fragile X-associated tremor/ataxia syndrome |
| Q36854284 | Expandable DNA repeats and human disease. |
| Q40714167 | Expanded CTG repeats inhibit neuronal differentiation of the PC12 cell line |
| Q34362347 | Expanded CUG repeat RNAs form hairpins that activate the double-stranded RNA-dependent protein kinase PKR |
| Q34142078 | Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy |
| Q39584664 | Expansion of the (CTG)(n) repeat in the 5'-UTR of a reporter gene impedes translation |
| Q40104035 | Expression pattern of muscleblind-like proteins differs in differentiating myoblasts |
| Q52009207 | Flies deficient in Muscleblind protein model features of myotonic dystrophy with altered splice forms of Z-band associated transcripts. |
| Q74607477 | Fragile-X syndrome and myotonic dystrophy: parallels and paradoxes |
| Q41503510 | Fuchs' Endothelial Corneal Dystrophy and RNA Foci in Patients With Myotonic Dystrophy |
| Q36852809 | Functional and intracellular localization properties of U6 promoter-expressed siRNAs, shRNAs, and chimeric VA1 shRNAs in mammalian cells |
| Q36924430 | Functional significance of the GAG trinucleotide-repeat polymorphism in the gene for the catalytic subunit of gamma-glutamylcysteine ligase. |
| Q44420167 | Hammerhead ribozyme-mediated destruction of nuclear foci in myotonic dystrophy myoblasts |
| Q35030106 | High-content screening identifies small molecules that remove nuclear foci, affect MBNL distribution and CELF1 protein levels via a PKC-independent pathway in myotonic dystrophy cell lines |
| Q38060527 | How do C9ORF72 repeat expansions cause amyotrophic lateral sclerosis and frontotemporal dementia: can we learn from other noncoding repeat expansion disorders? |
| Q36186164 | Identification and characterization of modified antisense oligonucleotides targeting DMPK in mice and nonhuman primates for the treatment of myotonic dystrophy type 1. |
| Q36051366 | Identification of Plant-derived Alkaloids with Therapeutic Potential for Myotonic Dystrophy Type I |
| Q35758167 | Imaging of single mRNAs in the cytoplasm of living cells |
| Q33588075 | Immortalized human myotonic dystrophy muscle cell lines to assess therapeutic compounds. |
| Q24555640 | In vivo co-localisation of MBNL protein with DMPK expanded-repeat transcripts |
| Q33786263 | Intracellular Distribution and Nuclear Activity of Antisense Oligonucleotides After Unassisted Uptake in Myoblasts and Differentiated Myotubes In Vitro. |
| Q33698593 | Lomofungin and dilomofungin: inhibitors of MBNL1-CUG RNA binding with distinct cellular effects |
| Q34930681 | Long CTG Tracts from the Myotonic Dystrophy Gene Induce Deletions and Rearrangements during Recombination at the APRT Locus in CHO Cells |
| Q33808904 | Long tract of untranslated CAG repeats is deleterious in transgenic mice |
| Q34142085 | Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing |
| Q24311381 | MBNL and CELF proteins regulate alternative splicing of the skeletal muscle chloride channel CLCN1 |
| Q24310407 | MBNL1 associates with YB-1 in cytoplasmic stress granules |
| Q28293693 | MBNL1 is the primary determinant of focus formation and aberrant insulin receptor splicing in DM1 |
| Q24315686 | MKBP, a novel member of the small heat shock protein family, binds and activates the myotonic dystrophy protein kinase |
| Q88712420 | Mechanisms of skeletal muscle wasting in a mouse model for myotonic dystrophy type 1 |
| Q35064141 | Microsatellite repeat instability and neurological disease |
| Q36640173 | Misregulation of alternative splicing causes pathogenesis in myotonic dystrophy. |
| Q41560194 | Molecular Effects of the CTG Repeats in Mutant Dystrophia Myotonica Protein Kinase Gene |
| Q59358387 | Molecular Therapies for Muscular Dystrophies |
| Q24548314 | Molecular basis for impaired muscle differentiation in myotonic dystrophy |
| Q38352207 | Molecular biology. Neutralizing toxic RNA. |
| Q38326275 | Molecular mechanisms in DM1 - a focus on foci. |
| Q36295966 | Muscle chloride channel dysfunction in two mouse models of myotonic dystrophy. |
| Q24299521 | Muscleblind proteins regulate alternative splicing |
| Q42154009 | Muscleblind-like proteins: similarities and differences in normal and myotonic dystrophy muscle |
| Q36323744 | Mutant DMPK 3'-UTR transcripts disrupt C2C12 myogenic differentiation by compromising MyoD. |
| Q34073069 | Myoblasts generated by lentiviral mediated MyoD transduction of myotonic dystrophy type 1 (DM1) fibroblasts can be used for assays of therapeutic molecules |
| Q35633172 | Myogenic defects in myotonic dystrophy |
| Q39012035 | Myotonic Dystrophy Type 2: An Update on Clinical Aspects, Genetic and Pathomolecular Mechanism |
| Q88453318 | Myotonic Dystrophy and Developmental Regulation of RNA Processing |
| Q33867667 | Myotonic dystrophies 1 and 2: complex diseases with complex mechanisms. |
| Q87411199 | Myotonic dystrophy |
| Q73408342 | Myotonic dystrophy protein kinase (DMPK) induces actin cytoskeletal reorganization and apoptotic-like blebbing in lens cells |
| Q35926958 | Myotonic dystrophy type 2 and related myotonic disorders |
| Q34446614 | Myotonic dystrophy--a multigene disorder. |
| Q35738537 | Myotonic dystrophy: RNA pathogenesis comes into focus |
| Q38855524 | Myotonic dystrophy: approach to therapy |
| Q34778128 | Myotonic dystrophy: clinical and molecular parallels between myotonic dystrophy type 1 and type 2. |
| Q34658838 | Myotonic dystrophy: molecular windows on a complex etiology |
| Q74057903 | Myotonic dystrophy: the role of the CUG triplet repeats in splicing of a novel DMPK exon and altered cytoplasmic DMPK mRNA isoform ratios |
| Q30361778 | NKX2-5, a modifier of skeletal muscle pathology due to RNA toxicity. |
| Q38051910 | Neurodegeneration as an RNA disorder |
| Q34462377 | Neuropathology does not Correlate with Regional Differences in the Extent of Expansion of CTG Repeats in the Brain with Myotonic Dystrophy Type 1 |
| Q30427374 | New function for the RNA helicase p68/DDX5 as a modifier of MBNL1 activity on expanded CUG repeats |
| Q58923911 | Normal myogenesis and increased apoptosis in myotonic dystrophy type-1 muscle cells |
| Q33933843 | Nuclear proteins and cell death in inherited neuromuscular disease |
| Q64989527 | Of Mice and Men: Advances in the Understanding of Neuromuscular Aspects of Myotonic Dystrophy. |
| Q38172172 | Oligonucleotide-Based Therapy for FTD/ALS Caused by the C9orf72 Repeat Expansion: A Perspective |
| Q37569144 | Pathogenic RNAs in microsatellite expansion disease |
| Q37414636 | Pathogenic mechanisms of myotonic dystrophy |
| Q93073825 | Peptide-conjugated oligonucleotides evoke long-lasting myotonic dystrophy correction in patient-derived cells and mice |
| Q37831858 | Perspectives on gene therapy in myotonic dystrophy type 1. |
| Q40794185 | Phenylbutazone induces expression of MBNL1 and suppresses formation of MBNL1-CUG RNA foci in a mouse model of myotonic dystrophy |
| Q57268499 | Potassium currents in human myogenic cells from healthy and congenital myotonic dystrophy foetuses |
| Q34687780 | Quality control of gene expression in the nucleus |
| Q35474587 | RNA Foci, CUGBP1, and ZNF9 are the primary targets of the mutant CUG and CCUG repeats expanded in myotonic dystrophies type 1 and type 2 |
| Q36189974 | RNA imaging in living cells - methods and applications |
| Q36673701 | RNA interference targeting CUG repeats in a mouse model of myotonic dystrophy |
| Q33746283 | RNA metabolism in neurodegenerative disease. |
| Q38928719 | RNA toxicity induced by expanded CAG repeats in Huntington's disease |
| Q35789502 | RNA-binding protein misregulation in microsatellite expansion disorders |
| Q37110656 | RNA-binding proteins and post-transcriptional gene regulation |
| Q37992334 | RNA-binding proteins in microsatellite expansion disorders: mediators of RNA toxicity |
| Q34257340 | RNase H-mediated degradation of toxic RNA in myotonic dystrophy type 1 |
| Q24290177 | Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy |
| Q36616570 | Retention of hexanucleotide repeat-containing intron in C9orf72 mRNA: implications for the pathogenesis of ALS/FTD |
| Q38352202 | Reversal of RNA dominance by displacement of protein sequestered on triplet repeat RNA. |
| Q34984541 | Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy |
| Q30435398 | Reversible model of RNA toxicity and cardiac conduction defects in myotonic dystrophy |
| Q42566971 | Ribonuclear foci at the neuromuscular junction in myotonic dystrophy type 1. |
| Q41051948 | Ribozyme-mediated trans-splicing of a trinucleotide repeat. |
| Q37981785 | Role of noncoding RNAs in trinucleotide repeat neurodegenerative disorders |
| Q83034979 | Selective silencing of mutated mRNAs in DM1 by using modified hU7-snRNAs |
| Q35237068 | Short antisense-locked nucleic acids (all-LNAs) correct alternative splicing abnormalities in myotonic dystrophy |
| Q35937357 | Six Serum miRNAs Fail to Validate as Myotonic Dystrophy Type 1 Biomarkers |
| Q47747960 | Somatic instability of the expanded CTG triplet repeat in myotonic dystrophy type 1 is a heritable quantitative trait and modifier of disease severity |
| Q33407042 | Spinocerebellar ataxia type 8 larger triplet expansion alters histone modification and induces RNA foci |
| Q41683485 | Splicing of human chloride channel 1. |
| Q35623474 | Stabilization of expanded (CTG)•(CAG) repeats by antisense oligonucleotides |
| Q38430517 | Structure and Dynamics of RNA Repeat Expansions That Cause Huntington's Disease and Myotonic Dystrophy Type 1. |
| Q33681082 | Studies of FRAXA and FRAXE in women with premature ovarian failure |
| Q38759837 | Sustained expression of FMR1 mRNA from reactivated fragile X syndrome alleles after treatment with small molecules that prevent trimethylation of H3K27. |
| Q74604409 | Synthesis of long trinucleotide repeats in vitro |
| Q37778406 | Tackling the pathogenesis of RNA nuclear retention in myotonic dystrophy |
| Q34565412 | Tandem repeat distribution of gene transcripts in three plant families |
| Q34459257 | Targeting nuclear RNA for in vivo correction of myotonic dystrophy |
| Q57897029 | Tau protein isoforms, phosphorylation and role in neurodegenerative disorders11These authors contributed equally to this work |
| Q33903996 | The 3' untranslated region of messenger RNA: A molecular 'hotspot' for pathology? |
| Q24290741 | The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing |
| Q41968306 | The DMPK gene of severely affected myotonic dystrophy patients is hypermethylated proximal to the largely expanded CTG repeat |
| Q36842039 | The cell biology of disease: cellular and molecular mechanisms underlying muscular dystrophy |
| Q24533443 | The fragile-X premutation: a maturing perspective |
| Q38045121 | The myotonic dystrophies: molecular, clinical, and therapeutic challenges |
| Q24634680 | The pathobiology of splicing |
| Q34186276 | The splice of life: alternative splicing and neurological disease |
| Q34133251 | The structural basis of myotonic dystrophy from the crystal structure of CUG repeats |
| Q37455625 | Therapeutic advances in muscular dystrophy |
| Q35924075 | Therapeutic impact of systemic AAV-mediated RNA interference in a mouse model of myotonic dystrophy. |
| Q26750577 | There has been an awakening: Emerging mechanisms of C9orf72 mutations in FTD/ALS |
| Q36423096 | Tibialis anterior muscle needle biopsy and sensitive biomolecular methods: a useful tool in myotonic dystrophy type 1 |
| Q34291180 | Transcription and nuclear transport of CAG/CTG trinucleotide repeats in yeast |
| Q37147158 | Transcriptional and post-transcriptional impact of toxic RNA in myotonic dystrophy |
| Q77359888 | Transcriptional properties of RNA polymerase II within triplet repeat-containing DNA from the human myotonic dystrophy and fragile X loci |
| Q45822517 | Transcriptionally correlated subcellular dynamics of MBNL1 during lens development and their implication for the molecular pathology of myotonic dystrophy type 1. |
| Q34267388 | Transgenic mouse models for myotonic dystrophy type 1 (DM1) |
| Q92846144 | Transplantation studies reveal internuclear transfer of toxic RNA in engrafted muscles of myotonic dystrophy 1 mice |
| Q35633648 | Triplet repeat RNA structure and its role as pathogenic agent and therapeutic target |
| Q33936621 | Triplet repeat expansion in neuromuscular disease |
| Q34446513 | Triplet repeats, RNA secondary structure and toxic gain-of-function models for pathogenesis |
| Q34310291 | Ubiquitous expression of CUG or CAG trinucleotide repeat RNA causes common morphological defects in a Drosophila model of RNA-mediated pathology |
| Q97423828 | Unexpected Mutations by CRISPR-Cas9 CTG Repeat Excision in Myotonic Dystrophy and Use of CRISPR Interference as an Alternative Approach |
| Q38289261 | Viral Vector-Mediated Antisense Therapy for Genetic Diseases |
| Q44409505 | Viral vector producing antisense RNA restores myotonic dystrophy myoblast functions |
| Q24548860 | Visualization of double-stranded RNAs from the myotonic dystrophy protein kinase gene and interactions with CUG-binding protein |
| Q38615610 | cncRNAs: Bi-functional RNAs with protein coding and non-coding functions |
| Q83225752 | deregulation is associated with cardiac conduction defects in myotonic dystrophy type 1 |
Search more.